One of the pathological hallmarks of AD is abnormal accumulation of amyloid-β peptide (Aβ), derived from the amyloid precursor protein (APP) via proteolytic cleavages by β- and γ-secretases [1]. This evidence concerns the gene APP and Alzheimer disease.